Skip to main content
    Q

    Quoin Pharmaceuticals Ltd DRC (QNRX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.70
    -0.05 (-1.33%)

    Market Cap: $17.78M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Quoin Pharmaceuticals Ltd DRC (QNRX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Quoin Pharmaceuticals Ltd DRC are Quantum BioPharma (QNTM), Quince Therapeutics (QNCX) and Context Therapeutics (CNTX). By market cap, Quoin Pharmaceuticals Ltd DRC ranks 5th of the 13 companies on this page; Rein Therapeutics (RNTX) is the largest at $47.63M.

    Peer Comparison

    QNRX's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Quoin Pharmaceuticals Ltd DRC (QNRX)$17.78MN/AN/A0.0%N/A0.0%0.00%
    Quantum BioPharma Ltd. (QNTM)$10.35MN/AN/A0.0%-150.1%0.0%0.00%
    Quince Therapeutics, Inc. (QNCX)$32.27MN/AN/A0.0%N/A0.0%0.00%
    Context Therapeutics Inc (CNTX)$16.61MN/AN/A0.0%N/A0.0%0.00%
    Pluri Inc. (PLUR)$15.09MN/A8.7x0.0%-650.8%-15.8%0.00%
    Neuphoria Therapeutics Inc (NEUP)$13.80MN/AN/A0.0%N/A0.0%0.00%
    Cocrystal Pharma Inc (COCP)$18.88MN/A39.2x0.0%N/A26.9%0.00%
    Citius Pharmaceuticals Inc (CTXR)$14.69MN/A1.9x0.0%-84.3%0.0%0.00%
    Cyclerion Therapeutics Inc (CYCN)$15.73MN/AN/A0.0%N/A-43.2%0.00%
    Vyome Holdings, Inc. (HIND)$11.09MN/AN/A0.0%N/A67.5%0.00%
    Rein Therapeutics Inc (RNTX)$47.63MN/AN/A0.0%N/A0.0%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    Passage Bio Inc (PASG)$13.68MN/AN/A0.0%N/A0.0%0.00%
    Peer median$15.41MN/A5.4x0.0%-400.5%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Quoin Pharmaceuticals Ltd DRC, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Quantum BioPharma Ltd. (QNTM)
    Quantum BioPharma Ltd. (QNTM) is an innovative biotechnology company focused on advancing transformative therapies for oncology and autoimmune diseases.
    QNTM competitors
    Quince Therapeutics, Inc. (QNCX)
    Quince Therapeutics, Inc., a biopharmaceutical company, is focused on advancing precision therapies for rare and debilitating diseases.
    Context Therapeutics Inc (CNTX)
    Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid...
    CNTX competitors
    Pluri Inc. (PLUR)
    Pluri Inc. is an innovative biotechnology company at the forefront of regenerative medicine and immunotherapy...
    PLUR competitors
    Neuphoria Therapeutics Inc (NEUP)
    Neuphoria Therapeutics Inc (Ticker: NEUP) is a groundbreaking biotechnology firm focused on revolutionizing mental health disorders treatment via psychedelic...
    NEUP competitors
    Cocrystal Pharma Inc (COCP)
    Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic...
    COCP competitors
    Citius Pharmaceuticals Inc (CTXR)
    Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products.
    CTXR competitors
    Cyclerion Therapeutics Inc (CYCN)
    Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development...
    Vyome Holdings, Inc. (HIND)
    Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States...
    HIND competitors
    Rein Therapeutics Inc (RNTX)
    Rein Therapeutics Inc (RNTX) is a forward-thinking biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative disorders...
    RNTX competitors
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    Passage Bio Inc (PASG)
    Passage Bio, Inc., a genetic drug company, develops transformative therapies for rare monogenic central nervous system (CNS) diseases.
    PASG competitors

    Frequently Asked Questions About QNRX

    Who are Quoin Pharmaceuticals Ltd DRC's main competitors?

    The companies most similar to Quoin Pharmaceuticals Ltd DRC include Quantum BioPharma (QNTM), Quince Therapeutics (QNCX), Context Therapeutics (CNTX), Pluri (PLUR) and Neuphoria Therapeutics (NEUP), listed from the closest match.

    Who is Quoin Pharmaceuticals Ltd DRC's biggest competitor?

    Rein Therapeutics (RNTX) is the largest of the similar companies at $47.63M; Quantum BioPharma (QNTM) is the closest match by business profile, size, sector and industry.

    How does QNRX stock compare with its competitors?

    QNRX's net margin is 0.0% against a peer median of 0.0%.

    Which of Quoin Pharmaceuticals Ltd DRC's competitors pays a higher dividend?

    Quoin Pharmaceuticals Ltd DRC pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Quoin Pharmaceuticals Ltd DRC bigger than its competitors?

    No. Quoin Pharmaceuticals Ltd DRC is 5th by market cap among the 13 companies on this page; the largest is Rein Therapeutics (RNTX) at $47.63M.